Literature DB >> 19806034

Towards revealing the structure of bacterial inclusion bodies.

Lei Wang1.   

Abstract

Protein aggregation is a widely observed phenomenon in human diseases, biopharmaceutical production, and biological research. Protein aggregates are generally classified as highly ordered, such as amyloid fibrils, or amorphous, such as bacterial inclusion bodies. Amyloid fibrils are elongated filaments with diameters of 6-12 nm, they are comprised of residue-specific cross-beta structure, and display characteristic properties, such as binding with amyloid-specific dyes. Amyloid fibrils are associated with dozens of human pathological conditions, including Alzheimer disease and prion diseases. Distinguished from amyloid fibrils, bacterial inclusion bodies display apparent amorphous morphology. Inclusion bodies are formed during high-level recombinant protein production, and formation of inclusion bodies is a major concern in biotechnology. Despite of the distinctive morphological difference, bacterial inclusion bodies have been found to have some amyloid-like properties, suggesting that they might contain structures similar to amyloid-like fibrils. Recent structural data further support this hypothesis, and this review summarizes the latest progress towards revealing the structural details of bacterial inclusion bodies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19806034      PMCID: PMC2802778          DOI: 10.4161/pri.3.3.9922

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  82 in total

1.  The HET-s prion protein of the filamentous fungus Podospora anserina aggregates in vitro into amyloid-like fibrils.

Authors:  Suzana Dos Reis; Bénédicte Coulary-Salin; Vincent Forge; Ioan Lascu; Joël Bégueret; Sven J Saupe
Journal:  J Biol Chem       Date:  2001-12-03       Impact factor: 5.157

Review 2.  Protein folding and misfolding.

Authors:  Christopher M Dobson
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

3.  Protein compositional analysis of inclusion bodies produced in recombinant Escherichia coli.

Authors:  U Rinas; J E Bailey
Journal:  Appl Microbiol Biotechnol       Date:  1992-08       Impact factor: 4.813

4.  Recombinant protein solubility - does more mean better?

Authors:  Nuria González-Montalbán; Elena García-Fruitós; Antonio Villaverde
Journal:  Nat Biotechnol       Date:  2007-07       Impact factor: 54.908

5.  Specific aggregation of partially folded polypeptide chains: the molecular basis of inclusion body composition.

Authors:  M A Speed; D I Wang; J King
Journal:  Nat Biotechnol       Date:  1996-10       Impact factor: 54.908

Review 6.  Protein aggregation: folding aggregates, inclusion bodies and amyloid.

Authors:  A L Fink
Journal:  Fold Des       Date:  1998

7.  Mycobacterium tuberculosis produces pili during human infection.

Authors:  Christopher J Alteri; Juan Xicohténcatl-Cortes; Sonja Hess; Guillermo Caballero-Olín; Jorge A Girón; Richard L Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-08       Impact factor: 11.205

8.  Functional amyloids as natural storage of peptide hormones in pituitary secretory granules.

Authors:  Samir K Maji; Marilyn H Perrin; Michael R Sawaya; Sebastian Jessberger; Krishna Vadodaria; Robert A Rissman; Praful S Singru; K Peter R Nilsson; Rozalyn Simon; David Schubert; David Eisenberg; Jean Rivier; Paul Sawchenko; Wylie Vale; Roland Riek
Journal:  Science       Date:  2009-06-18       Impact factor: 47.728

9.  Bacterial inclusion bodies contain amyloid-like structure.

Authors:  Lei Wang; Samir K Maji; Michael R Sawaya; David Eisenberg; Roland Riek
Journal:  PLoS Biol       Date:  2008-08-05       Impact factor: 8.029

10.  Learning about protein solubility from bacterial inclusion bodies.

Authors:  Mónica Martínez-Alonso; Nuria González-Montalbán; Elena García-Fruitós; Antonio Villaverde
Journal:  Microb Cell Fact       Date:  2009-01-08       Impact factor: 5.328

View more
  28 in total

Review 1.  Protein folding and aggregation in bacteria.

Authors:  Raimon Sabate; Natalia S de Groot; Salvador Ventura
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

2.  Overexpressed Arabidopsis Annexin4 accumulates in inclusion body-like structures.

Authors:  Careen Khachatoorian; Rigoberto A Ramirez; Fernando Hernandez; Raphael Serna; Ernest Y Kwok
Journal:  Acta Histochem       Date:  2015-03-26       Impact factor: 2.479

3.  Solid-state nuclear magnetic resonance (NMR) spectroscopy of human immunodeficiency virus gp41 protein that includes the fusion peptide: NMR detection of recombinant Fgp41 in inclusion bodies in whole bacterial cells and structural characterization of purified and membrane-associated Fgp41.

Authors:  Erica P Vogel; Jaime Curtis-Fisk; Kaitlin M Young; David P Weliky
Journal:  Biochemistry       Date:  2011-10-31       Impact factor: 3.162

4.  Strain conformation controls the specificity of cross-species prion transmission in the yeast model.

Authors:  Anastasia V Grizel; Aleksandr A Rubel; Yury O Chernoff
Journal:  Prion       Date:  2016-07-03       Impact factor: 3.931

5.  Multidimensional structure-activity relationship of a protein in its aggregated states.

Authors:  Lei Wang; David Schubert; Michael R Sawaya; David Eisenberg; Roland Riek
Journal:  Angew Chem Int Ed Engl       Date:  2010-05-25       Impact factor: 15.336

Review 6.  Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.

Authors:  Aleš Berlec; Borut Strukelj
Journal:  J Ind Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.346

7.  Quality control of inclusion bodies in Escherichia coli.

Authors:  Britta Jürgen; Antje Breitenstein; Vlada Urlacher; Knut Büttner; Hongying Lin; Michael Hecker; Thomas Schweder; Peter Neubauer
Journal:  Microb Cell Fact       Date:  2010-05-28       Impact factor: 5.328

8.  Amyloid-like protein inclusions in tobacco transgenic plants.

Authors:  Anna Villar-Piqué; Raimon Sabaté; Oriol Lopera; Jordi Gibert; Josep Maria Torne; Mireya Santos; Salvador Ventura
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

9.  Combining in Vitro Folding with Cell Free Protein Synthesis for Membrane Protein Expression.

Authors:  Paul J Focke; Christopher Hein; Beate Hoffmann; Kimberly Matulef; Frank Bernhard; Volker Dötsch; Francis I Valiyaveetil
Journal:  Biochemistry       Date:  2016-07-21       Impact factor: 3.162

10.  Enhancing the Yield of Active Recombinant Chitobiase by Physico-Chemical and In Vitro Refolding Studies.

Authors:  Arun Kumar Dangi; Praveen Rishi; Rupinder Tewari
Journal:  Protein J       Date:  2016-02       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.